Healthcare -
Biotechnology - NASDAQ - US
$ 1.055
-4.09 %
$ 55.6 M
Market Cap
-0.36
P/E
ALXO - OTHER CURRENT LIABILITIES
Other Current Liabilities ALXO - ALX Oncology Holdings Inc.
25.8 M
LAST VALUE
54.74%
2 YEAR CAGR
85.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR